不同类型润肤剂预防婴儿特应性皮炎的系统评价与网状Meta分析
该系统评价与网状Meta分析检索PubMed、EMBASE和Cochrane图书馆至2022年2月28日,纳入11项研究,比较不同类型润肤剂预防婴儿特应性皮炎(AD)的效果。直接Meta分析显示早期应用润肤剂可有效预防高危婴儿AD发生(风险比[RR] 0.64,95%置信区间[CI] 0.47至0.88)。网状Meta分析提示润肤乳液可能是更优选择,全人群累积排名曲线下面积(SUCRA)为82.6%,高危人群为78.0%,食物致敏人群为79.2%;接受润肤剂的受试者更频繁经历不良事件。
要点
- 早期应用润肤剂可有效预防高危婴儿AD发生(RR 0.64,95%CI 0.47至0.88)。
- 网状Meta分析提示润肤乳液可能是预防婴儿AD的更优选择。
- 接受润肤剂的受试者更频繁经历不良事件。
核心结论
- 早期应用润肤剂是预防高危婴儿AD发生的有效策略,润肤乳液可能是最优类型。
- 需要未来精心设计的大规模研究来验证这些发现。
研究设计与样本
- 系统评价与网状Meta分析,检索PubMed、EMBASE和Cochrane图书馆从建库至2022年2月28日的研究。
- 纳入11项研究进行数据分析,使用Cochrane偏倚风险评估工具评价纳入研究质量,数据分析使用STATA 14.0。
主要发现
- 直接Meta分析显示早期应用润肤剂有效预防高危婴儿AD发生(RR 0.64,95%CI 0.47至0.88)。
- 网状Meta分析显示润肤乳液的全人群SUCRA为82.6%,高危人群为78.0%,食物致敏人群为79.2%。
- 接受润肤剂的受试者更频繁经历不良事件。
关键数值与推荐
- 早期应用润肤剂预防高危婴儿AD的RR为0.64(95%CI 0.47至0.88)。
- 润肤乳液预防婴儿AD的SUCRA:全人群82.6%,高危人群78.0%,食物致敏人群79.2%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要未来精心设计的大规模研究来验证这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prophylactic application of emollients has been an effective strategy against infant atopic dermatitis (AD); however, the difference of different emollients is unknown. We performed this network meta-analysis to compare different emollients in preventing infant AD. A systematic search was performed in PubMed, EMBASE and Cochrane library to identify relevant studies from their inception through 28 February, 2022. We evaluated the quality of eligible studies using the Cochrane risk of bias assessment tool. Data analysis was performed using STATA 14.0. Eleven studies were included for data analysis. Direct meta-analysis suggested that early application of emollients effectively prevented AD development in high-risk infants (risk ratio [RR], 0.64; 95% confidence interval [CI], 0.47 to 0.88). Network meta-analysis suggested that emollient emulsion might the better option for preventing infant AD development, with a surface under the cumulative ranking curve (SUCRA) of 82.6% for all populations, 78.0% for high-risk populations and 79.2% for populations with food sensitization. Moreover, subjects receiving emollients more frequently experienced adverse events. Overall, early application of emollients is an effective strategy for preventing AD development in high-risk infants and emollient emulsion may be the optimal type. Future study with well-designed and large scale are warranted to validate our findings.
引用
- Liang J, Hu F, Tang H, et al. Systematic review and network meta-analysis of different types of emollient for the prevention of atopic dermatitis in infants. J Eur Acad Dermatol Venereol. 2022. PMID: 36415973. doi:10.1111/jdv.18688
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。